| Camille Johnson, MD | |
|
2600 Scripture St, Denton, TX 76201-4315 | |
| (940) 382-1022 | |
| (940) 323-1190 |
| Full Name | Camille Johnson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 2600 Scripture St, Denton, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457732711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 280761 (Massachusetts) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | T8234 (Texas) | Primary |
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
The U.S. Food and Drug Administration today approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi.
The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched non-invasive prenatal genetic test (NIPT) technology. This technology has been developed by BGI in connection with the provision of its market leading NIPT, the NIFTY test.
Heart problems in children hospitalized with multisystem inflammatory syndrome (MIS-C)-an inflammatory condition triggered by COVID-were mostly gone within a few months, a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found.
Nearly 20 years ago, it was discovered that bacteria known as Helicobacter pylori were responsible for stomach ulcers. Since then, antibiotics have become the primary therapy used to combat the H. pylori infection, which affects approximately six percent of the world population and is also a primary cause of stomach cancer. But today the bacteria is growing increasingly resistant to antibiotics.
Immunologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have come up with a new technique that can be used both to fight tumors and to treat autoimmune diseases. A new grant from the Federal Ministry for Education and Research will enable the method to be developed further.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Camille Johnson, MD Po Box 911230, Dallas, TX 75391-7228 Ph: (972) 997-8000 | Camille Johnson, MD 2600 Scripture St, Denton, TX 76201-4315 Ph: (940) 382-1022 |
News Archive
The U.S. Food and Drug Administration today approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi.
The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched non-invasive prenatal genetic test (NIPT) technology. This technology has been developed by BGI in connection with the provision of its market leading NIPT, the NIFTY test.
Heart problems in children hospitalized with multisystem inflammatory syndrome (MIS-C)-an inflammatory condition triggered by COVID-were mostly gone within a few months, a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found.
Nearly 20 years ago, it was discovered that bacteria known as Helicobacter pylori were responsible for stomach ulcers. Since then, antibiotics have become the primary therapy used to combat the H. pylori infection, which affects approximately six percent of the world population and is also a primary cause of stomach cancer. But today the bacteria is growing increasingly resistant to antibiotics.
Immunologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have come up with a new technique that can be used both to fight tumors and to treat autoimmune diseases. A new grant from the Federal Ministry for Education and Research will enable the method to be developed further.
› Verified 7 days ago
Jamal Mubarak, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 209 N. Bonnie Brae Street, Suite 300, Denton, TX 76201 Phone: 940-382-5864 Fax: 940-382-3939 | |
Dr. Seema Haq, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Colorado Blvd, Denton, TX 76210 Phone: 940-488-4767 Fax: 855-444-9702 | |
Asad Zamann, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3315 Colorado Blvd, Ste 102, Denton, TX 76210 Phone: 940-320-1708 Fax: 940-565-5457 | |
Dr. Awilda Michelle Luciano, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2665 Scripture Street, Denton, TX 76201 Phone: 940-387-8763 Fax: 940-535-5901 | |
Dr. Ajit M Dave, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3327 Colorado Blvd, Suite #200, Denton, TX 76210 Phone: 940-382-4060 Fax: 940-380-9282 | |
Dr. Sridhar Krishnamurthy Iyer, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 802 North Bonnie Brae Street, Suite 104, Denton, TX 76201 Phone: 940-565-0373 Fax: 940-565-0413 | |
Charles Hancock Wahlert, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 521 Bryan St, Denton, TX 76201 Phone: 940-380-1985 |